Apimeds Pharmaceuticals US, Inc (APUS) ownership: Top institutional holder: Hemenway Trust Co LLC ($490296.00). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Hemenway Trust Co LLC | 274000.00 | $490296.00 | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 95929.00 | $171617.00 | 2026-03-31 |
| VANGUARD GROUP INC | 58992.00 | $96747.00 | 2025-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 40051.00 | $71666.00 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 27893.00 | $49650.00 | 2025-09-30 |
| JANE STREET GROUP, LLC | 27188.00 | $44588.00 | 2025-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 24039.00 | $43006.00 | 2026-03-31 |
| CITADEL ADVISORS LLC | 13359.00 | $23512.00 | 2025-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2025-11-11 | |
| Sell | null | 2025-11-11 | |
| Sell | null | 2025-11-11 | |
| Sell | null | 2025-11-11 | |
| Sell | null | 2025-11-11 | |
| Sell | null | 2025-10-15 | |
| Sell | null | 2025-10-15 | |
| Sell | null | 2025-10-15 |
Back to APUS overview · APUS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.